Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Andro

This article was originally published in The Tan Sheet

Executive Summary

Sports supplement will be classified as a steroid in the coming months, Drug Czar Barry McCaffrey announces at a Citizenship Through Sports Alliance meeting in Arlington, Va. June 26. President Clinton's top drug policy adviser maintains androstenedione fits the criteria to be labeled a steroid in two of the three government tests used to classify hormonal substances. Groups such as the Blue Cross/Blue Shield's Healthy Competition Foundation have asked pro athletes to stop using performance enhancing substances, which gained notoriety due to their use by popular stars such as baseball slugger Mark McGwire, who has since stopped using andro (1"The Tan Sheet" April 3, p. 6)

You may also be interested in...



FDA/DEA Ban Of Andro Sought By Blue Cross & Blue Shield Foundation

A youth sports advocacy group is attempting to halt the sale and use of androstenedione-containing dietary supplements with a dual-pronged initiative aimed at Major League Baseball players and federal regulators, including FDA.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091366

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel